Cardlytics Inc (NAS:CDLX)
$ 3.65 +0.090 (+2.53%) Market Cap: 21.49 Mil Enterprise Value: 183.34 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 32/100

Q2 2026 Cardlytics Inc Earnings Call Transcript

Aug 05, 2026 / 09:00PM GMT
Release Date Price: $4.09 (+1.74%)
Operator

Hello, everyone. Thank you for joining us, and welcome to the Q2 2026 Cardlytics Inc., earnings conference call. (Operator Instructions)

I will now hand the call over to Chris Cheng, Chief Legal Officer. Chris, please go ahead.

Chris Cheng
Cardlytics Inc - Chief Legal Officer

Good evening, and welcome to the Cardlytics' second-quarter 2026 financial results call.

Before we begin, let me remind everyone that today's discussion will contain forward-looking statements based on our current assumptions, expectations and beliefs, including expectations around our future financial performance and results, including for the third quarter of 2026, our capital structure and operational and product initiatives.

For a discussion on the specific risk factors that could cause our actual results to differ materially from today's discussion, please refer to the risk factors section of our 10-Q for the quarter ending June 30, 2026, which has been filed with the SEC.

Also during our call, we will discuss non-GAAP measures of our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot